Keystone Heart is focused on protecting the brain from emboli to reduce the risk of brain infarcts during TAVR, atrial fibrillation ablation and other structural heart procedures.

Latest News

Share this

Author: Keystone Heart

REPRISE III Results Are In!

As a part of our medical community, we wanted to make sure you were aware of a recent article published by TCTMD. Full results of the REPRISE III trial comparing the mechanically expanded Boston Scientific’s Lotus transcatheter aortic valve replacement system to Medtronic’s self-expanding first-and second-generation...


TCT 2017 Dr. Richard Smalling

Flash Debate and Discussion: CEP should be used judiciously in selected TAVR patients only. Presented by: Dr. Richard Smalling     Dr. Smalling is a native Texan who received his B.S. in Aerospace Engineering and M.S.M.E in Bio-Medical Engineering from UT Austin, a PhD from the UTHealth School of Biomedical...


TCT 2017 Dr. Samir Kapadia

Introducing: CEP is necessary and indicated for all TAVR procedures Presented by: Samir Kapadia DOWNLOAD THE SLIDES HERE   Samir Kapadia, MD, is the Section Head of Invasive and Interventional Cardiology, the Director of the Sones Cardiac Catheterization Laboratories, and Director of the Interventional Cardiology Fellowship Program in the...


TCT 2017 Dr. Pieter Stella

Introducing: A critical review of the neurological effects of invasive cardiac procedures: Do we need to do better? Presented by: Dr. Pieter Stella DOWNLOAD THE SLIDES HERE   Dr. Stella was trained as a cardiologist in the OLVG- Amsterdam and did his fellowship in interventional cardiology at the University...


TCT 2017 Dr. Tamim Nazif

Co-Chair and Presenting on: Practical Considerations and Design Requirements for clinically relevant CEP: The Keystone TriGUARD 3  device. Presented by: Dr. Tamim Nazif DOWNLOAD THE SLIDES HERE   Tamim Nazif, MD is an Assistant Professor of Medicine at Columbia University Irving Medical Center, the Director of Research for the Center...


TCT 2017 Dr. Jeffery Moses

Building the Evidence for CEP in TAVR: Critical review of the clinical trial data and REFLECT update. Presented by: Dr. Jeffrey Moses DOWNLOAD THE SLIDES HERE   An internationally recognized interventional cardiologist, Dr. Jeffrey W. Moses Professor of Medicine at Columbia University Medical Center, completed medical school at the...


TCT 2017 Dr. Raj Makkar

Progress in Cerebral Embolic Protection This Presentation was Given at the Keystone Heart Breakfast Symposium at TCT 2017 Introducing: Progress in Cerebral Embolic Protection Wednesday, November 1st - 6:30AM Breakfast 7:00-8:00AM Program Colorado Convention Center Room 501 Co-Chairs – Tamim Nazif and Raj Makkar Flash debate and discussion – moderated by...


TCT 2017 Dr. Alexandra Lansky

The search for meaningful measures of clinical efficacy:  NeuroARC and beyond. Presented by: Dr. Alexandra Lansky DOWNLOAD THE SLIDES HERE Alexandra Lansky, MD, FESC, FACC, is Director of the Heart and Vascular Clinical Research Program at Yale University, School of Medicine and Director of the Yale Cardiovascular Research...